Emery E A, Ahmad S, Koethe J D, Skipper A, Perlmutter S, Paskin D L
Pennsylvania Hospital, Philadelphia, USA.
Nutr Clin Pract. 1997 Apr;12(2):72-5. doi: 10.1177/011542659701200272.
Diarrhea occurs frequently in the critically ill tube-fed population and may result from a multitude of causes. Despite the availability of antidiarrheal medications, diarrhea associated with enteral feedings remains a problem for clinicians and for the patients affected by it. We tested the hypothesis that administration of banana flakes would control diarrhea in critically ill patients receiving enteral feedings. Thirty-one patients with diarrhea and receiving enteral feedings were randomized to receive either banana flakes or medical treatment for diarrhea. Medical treatments included the use of pharmacological agents according to the discretion of the patient's physician or reducing feeding rates. Both banana flakes and medical treatments reduced the severity of diarrhea in critically ill tube-fed patients. Over the course of treatment, mean diarrhea scores were 21.64 +/- 7.81 for the banana flake group and 25.41 +/- 9.76 for the medical group. These differences were not statistically significant. Both groups achieved similar levels of nutrition support. The banana flake group had less diarrhea clinically, with 57% of the subjects diarrhea free on their last study day as opposed to 24% of the medically treated subjects. This occurred despite a threefold increase in the number of patients testing positive for Clostridium difficile toxin in the banana flake group. We conclude that banana flakes can be used as a safe, cost-effective treatment for diarrhea in critically ill tube-fed patients. Banana flakes can be given concurrently with a workup for C. difficile colitis, thereby expediting treatment of diarrhea.
腹泻在危重症鼻饲患者中频繁发生,可能由多种原因引起。尽管有止泻药物,但与肠内喂养相关的腹泻对临床医生和受其影响的患者来说仍然是个问题。我们检验了这样一个假设:给予香蕉片可以控制接受肠内喂养的危重症患者的腹泻。31名腹泻且接受肠内喂养的患者被随机分为两组,分别接受香蕉片治疗或腹泻药物治疗。药物治疗包括根据患者医生的判断使用药物或降低喂养速度。香蕉片治疗和药物治疗均降低了危重症鼻饲患者腹泻的严重程度。在治疗过程中,香蕉片组的平均腹泻评分为21.64±7.81,药物治疗组为25.41±9.76。这些差异无统计学意义。两组获得了相似水平的营养支持。香蕉片组临床上腹泻较少,在最后研究日,57%的受试者无腹泻,而药物治疗组这一比例为24%。尽管香蕉片组艰难梭菌毒素检测呈阳性的患者数量增加了两倍,但仍出现了这种情况。我们得出结论,香蕉片可作为危重症鼻饲患者腹泻的一种安全、经济有效的治疗方法。香蕉片可与艰难梭菌结肠炎的检查同时进行,从而加快腹泻的治疗。